Galderma is the leading company solely dedicated to skin and advancing the future of dermatology. We deliver an innovative, science-based portfolio of sophisticated brands and services across Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Through trusted partnerships with healthcare professionals, we ensure to meet individual consumer and patient needs with superior outcomes.
市場タイムラインとシグナルフィードを解放
過去 90 日間に 306 件のシグナル。
この企業が各市場へ参入した順序 — 古い順から新しい順へ
13 active postings
70 active postings
登録してシグナルフィードをすべて表示
Galderma の海外展開を競合と比較
Galderma自社バーは比較対象企業間の相対的な規模を示します。
列5| 企業 | 市場 | 新規市場 | モメンタム | アクティビティ | 拡大スコア |
|---|---|---|---|---|---|
 Galderma自社 | 34 | 0 | -57% | 250 | 35 |
Opérateur de Production Conditionnement FDS Jour
求人を見るBaie-d’Urfé, Quebec, Canada · 昨日
Employee Relations / Labor Relations (ER / LR) Specialist (Part-time position / 50%)
求人を見るWarsaw, Mazowieckie, Poland · 昨日
Sales Representative (Injectable Aesthetics) - Western Cape Town
求人を見るJohannesburg, Gauteng, South Africa · 一昨日
We’re excited to share insights from our new global anti-wrinkle treatment survey, revealing a clear shift in preferences toward high-performance solutions that deliver lasting results and drive innovation in aesthetics.Anti-wrinkle treatments are one of the most common injectable procedures in aesthetics. Results show that healthcare professionals prioritize performance above all. For patients, the value lies in both emotional impact and visible performance, with long-lasting and early results ...
終了We’re excited to share insights from our new global anti-wrinkle treatment survey, revealing a clear shift in preferences toward high-performance solutions that deliver lasting results and drive innovation in aesthetics.Anti-wrinkle treatments are one of the most common injectable procedures in aesthetics. Results show that healthcare professionals prioritize performance above all. For patients, the value lies in both emotional impact and visible performance, with long-lasting and early results ...
終了At Galderma, the President’s Club Awards are an opportunity to recognize our top-performing Sales colleagues from around the world. This year we held two exceptional events - first, in May, our leading U.S. Sales colleagues gathered in Cap Cana, Dominican Republic, for a well-earned celebration of their remarkable achievements.Then, just this past week, our top Sales colleagues from LATAM, EMEAC and JPAC joined together in Singapore, all in one place for the very first time. These celebrations r ...
終了ガルデルマ韓国がセタフィルSAラインを発売。敏感肌向け角質ケア製品。3重ピーリング成分と保湿成分を含む洗顔料とローションを展開。
ガルデルマは、アトピー性皮膚炎と結節性痒疹のためのIL-31阻害剤ネモリズマブを韓国で承認を受け、生物学的製剤市場に参入。
ガルデルマ韓国がアトピー性皮膚炎と結節性痒疹のかゆみを標的とするIL-31阻害剤ネモリズマブを発表。臨床試験で48時間以内のかゆみ緩和とEASI改善を示した。償還申請完了、2027年初頭発売目標。
認証済みメールと直通電話を解放
無料 · カード不要
Galderma の事業、市場、成長シグナルに関する簡潔な回答。
© 2026 Pubrio. 無断転載を禁じます。
